Desloratadine/pseudoephedrine
This is an old revision of this page, as edited by 2607:fea8:e300:b8c:f9d9:907a:58cc:3826 (talk) at 16:26, 1 April 2023 (pseudoephedrine has a more complex mechanism of action and some categories from each component don't really apply to the combined product). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Combination of | |
---|---|
Desloratadine | Antihistamine |
Pseudoephedrine | Decongestant |
Clinical data | |
Trade names | Clarinex-D, Aerinaze |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Desloratadine/pseudoephedrine, sold under the brand name Clarinex-D among others, is a medication used for the treatment of seasonal allergic rhinitis.[1][2]
Desloratadine/pseudoephedrine was approved for use in the United States in 2005[1][3] and in the European Union in July 2007.[2]
Medical uses
Desloratadine/pseudoephedrine is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.[2]
References
- ^ a b c "Clarinex-D 12 Hour- desloratadine and pseudoephedrine sulfate tablet, extended release". DailyMed. 15 March 2019. Retrieved 1 March 2020.
- ^ a b c d "Aerinaze EPAR". European Medicines Agency. Retrieved 1 March 2020.
- ^ "Drug Approval Package: Clarinex-D 24 Hour (Desloratadine/Pseudoephedrine Sulfate) NDA #021605". U.S. Food and Drug Administration (FDA). 9 May 2007. Retrieved 1 March 2020.
Further reading
- Anolik R (June 2009). "Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion". Expert Opin Drug Metab Toxicol. 5 (6): 683–94. doi:10.1517/17425250902980187. PMID 19473112. S2CID 22633518.
External links
- "Desloratadine mixture with pseudoephedrine". Drug Information Portal. U.S. National Library of Medicine.
Benzimidazoles (*) | |
---|---|
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
DRAsTooltip Dopamine releasing agents |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAsTooltip Norepinephrine releasing agents |
| ||||||||||||||
SRAsTooltip Serotonin releasing agents |
| ||||||||||||||
Others |
| ||||||||||||||
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Classes | |
---|---|
Antidepressants (Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |
|
![]() | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from March 2020
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles